Is Zealthy legit and worth it?
Zealthy is a real GLP-1 telehealth provider; we read its site and scored it 4.4/5 in our independent review (Strong Choice). Biggest plus: Brand-name FDA-approved medication options available. Watch-out: Low Trustpilot rating (3.2).
Scorecard: strongest in Clinical Quality (5.0/5) and Support (4.9/5); weakest in Reputation (3.2/5) and Authenticity (4.1/5).
Medications
Semaglutide, Tirzepatide (as listed on its site, 7 April 2026)
Monthly Cost
$39-$299 (as listed on its site, 7 April 2026)
Speed to Start
Fast
Prices and medications in this review are as listed on Zealthy’s site on 7 April 2026, unless a line is marked otherwise, and have not been re-checked since. Note added 13 October 2026.
Corrected 14 October 2026: this review previously gave a Better Business Bureau rating or listing status. We kept no record of where it came from, so it has been removed. Trustpilot figures in this review are as recorded in April 2026 and have not been re-checked.
About Zealthy
Zealthy is a newer entrant, founded in 2022, but has scaled remarkably fast — the company reports over 200,000 prescriptions written to date. The platform offers both semaglutide and tirzepatide in compounded and brand-name formulations, with monthly pricing spanning a wide range from $39 to $299. That entry point is among the lowest in the industry and reflects Zealthy’s aggressive pricing strategy aimed at making GLP-1 therapy accessible to a broader patient population.
Trust metrics for Zealthy are mixed. On Trustpilot, the platform holds a 3.2 rating across 5,940+ reviews, a moderate score that suggests inconsistent patient experiences. For a company processing the volume Zealthy claims, these trust indicators suggest growing pains — the infrastructure may not have scaled as smoothly as patient acquisition. Prospective patients should weigh the attractive pricing against this reality.
Clinically, Zealthy positions itself as an all-in-one care platform with a high-support model. Patients have access to nutrition coaching and dietitian consultations, services that most competitors either charge extra for or do not offer at all. The company also provides an insurance billing option, meaning patients with qualifying coverage may be able to use their health insurance to offset costs — a meaningful differentiator in a market dominated by cash-pay models. The combination of both semaglutide and tirzepatide gives patients medication flexibility that many providers lack.
The all-in-one model extends to Zealthy’s platform design. Patients can manage prescriptions, schedule consultations, track progress, and access educational resources through a single interface. For patients who find the fragmented nature of telehealth frustrating — one app for the doctor, another for the pharmacy, a third for coaching — Zealthy’s integrated approach simplifies the experience. The nutrition coaching component is particularly valuable during the early weeks of GLP-1 therapy, when dietary adjustments can significantly reduce side effects and improve outcomes.
Zealthy’s challenge is trust. The combination of rapid growth, aggressive pricing, and a middling Trustpilot score creates uncertainty about whether the clinical experience matches the marketing. We have seen this pattern before with fast-scaling telehealth companies: the product can be genuinely good, but operational growing pains in customer service and fulfillment drag down public perception. Patients who choose Zealthy should do so with realistic expectations about response times and should document all communications with their provider team.
Zealthy GLP-1 Medications
Screenshot of Zealthy, captured by 10 April 2026
Screenshot of Zealthy, captured by 10 April 2026
Screenshot of Zealthy, captured by 10 April 2026
Screenshot of Zealthy, captured by 10 April 2026
Screenshot of Zealthy, captured by 10 April 2026
At a Glance
Medications Offered
Semaglutide, Tirzepatide (as listed on its site, 7 April 2026)
Both
Cost & Insurance
- Monthly: $39-$299 (as listed on its site, 7 April 2026)
- 6-month estimate: $234-$1,794 (as listed on its site, 7 April 2026)
- Insurance: With or without insurance
- Self-pay: Yes
Clinical Features
- Lab testing: Not stated Corrected 13 October 2026: this line said “No”, but our research had recorded lab testing as variable, not absent. A con that repeated it has been removed.
- Dietitian access: Yes
- Pharmacies named: Not disclosed
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Spanish-language care announced by Zealthy (its own page, read 7 October 2026) Corrected 13 October 2026: this line said “Not available”, but our research had recorded it as unknown, and the provider’s own page says otherwise.
What the Zealthy Intake Looks Like
We walked through Zealthy’s GLP-1 weight-loss intake ourselves, from the opening email-and-password screen through the $39 first-month payment capture. The defining feature of Zealthy’s flow is that it captures payment before the medical history intake happens — the substantive clinical screening sits behind the credit-card screen, not in front of it.
The lowest score in our catalog for the pre-payment funnel. The only clinically relevant question asked before the credit-card screen is a single 4-option comorbidity multi-select. No FDA black-box screen, no mental health, no eating disorder, no substance use, no allergies, no medications, no pregnancy. Zealthy’s disclaimer states the medical history intake happens after payment — we have not walked that follow-up flow.
21 screens with an account-creation gate at screen 1 and a fake-urgency countdown timer (“YOUR APPROVAL EXPIRES IN 14:56”) two screens before the payment capture. The price is mild — $39 first month, $135/month thereafter — and a refund is offered if the patient is later deemed ineligible or insurance won’t cover the medication.
The 10 Stages
The single biggest difference between Zealthy and the other intakes in our catalog is the order of operations. Zealthy’s payment-screen disclaimer reads: “After putting your payment information in, your Zealthy provider will review your intake and help you get your GLP-1 medication, if appropriate. After you complete the order by clicking the secure ‘Get started’ button above, your information will be securely stored. You will then be asked to complete a short medical history intake and verify your identity.” The substantive clinical screening — the part where MTC, MEN-2, pancreatitis, mental health, allergies, current medications, and pregnancy ought to be asked — happens AFTER the credit card is captured, not before. Inside the pre-payment funnel we walked, the only medical question is a 4-option comorbidity checkbox.
Two screens before the payment capture, Zealthy displays a banner reading “YOUR APPROVAL EXPIRES IN 14:56” with a live countdown. The label “approval” is misleading — no licensed clinician has reviewed the patient’s medical history at this point, because the medical history hasn’t been collected yet. The “approval” being timed-out is the discount price, not a clinical decision. We flag this as a dark-pattern checkout pressure tactic borrowed from e-commerce, applied to a regulated medical context.
No FDA black-box screen of any kind — MTC, MEN-2, and pancreatitis are not asked. No mental-health question, no PHQ-2/PHQ-9, no suicidality. No eating-disorder screen. No substance or alcohol screen. No allergy capture. No current-medication or drug-interaction list. No blood pressure or resting heart rate. No diabetes type. No pregnancy or breastfeeding. No family history. No thyroid history. No diet or exercise history depth beyond a single 4-option “eating troubles” multi-select. No ID upload and no phone OTP. The on-screen disclaimer indicates these questions are asked in a follow-up “short medical history intake” after payment, but we did not walk that flow.
Zealthy charges $39 for the first month (“Last Chance: Sale Ends May 1st” banner) and a typical $135/month thereafter. The product positioning is “Prescription to GLP-1 medications and access to affordable compounded semaglutide or tirzepatide” with insurance prior-authorization assistance for brand-name. The disclaimer promises a full refund of the $39 if the patient is later deemed not medically eligible OR if the patient’s insurance will not cover the medication for any reason. Membership cancellation is “any time.”
Source: GLP-1.Reviews editorial walkthrough on April 29, 2026. We completed every screen of the Zealthy weight-loss intake using a representative GLP-1 candidate persona and stopped at the payment-capture screen. The post-payment medical history intake was not walked.
Opens getzealthy.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
Start your GLP-1 weight loss journey with Zealthy today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. We read providers’ own pages and public records and publish what we find, with the date we checked.
Corrected 13 October 2026: this review showed a “Verified Provider” badge and said our scores were “based on verified data and standardized criteria”. Neither described a check we had done, so both have been removed.
